Publicaciones en las que colabora con Valentín Cuervas Mons Martínez (16)

2022

  1. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  2. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

2021

  1. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884

  2. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

    Gastroenterology, Vol. 160, Núm. 4, pp. 1151-1163.e3

2020

  1. COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry

    The Lancet Gastroenterology and Hepatology

2019

  1. Mast cell-mediated splanchnic cholestatic inflammation

    Clinics and Research in Hepatology and Gastroenterology, Vol. 43, Núm. 5, pp. 561-574

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Mast cell stabilization with ketotifen decreases il-13 and cgrp in the ascitic fluid of rats with microsurgical cholestasis

    Revista española de investigaciones quirúrgicas, Vol. 21, Núm. 1, pp. 3-7

2017

  1. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil

    Liver Transplantation, Vol. 23, Núm. 4, pp. 498-509

  2. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

2015

  1. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

    Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065

  2. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2005

  1. Five-year follow-up of a trial comparing tacrolimus and cyclosporine microemulsion in liver transplantation

    Transplantation Proceedings

  2. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus

    Transplantation Proceedings

1999

  1. Late orthotopic liver retransplant: Indications and survival

    Transplantation Proceedings

  2. Registro espanol de trasplante hepatico (1984-1997)

    Transplantology: Journal of Cell and Organ Transplantation, Vol. 10, Núm. 2, pp. 52-59